Literature DB >> 12556699

CRF06-cpx is the predominant HIV-1 variant in AIDS patients from Ouagadougou, the capital city of Burkina Faso.

Rasmata Ouédraogo-Traoré1, Celine Montavon, Thomas Sanou, Nicole Vidal, Lassana Sangaré, Idrissa Sanou, Robert Soudré, Souleymane Mboup, Eric Delaporte, Martine Peeters.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12556699     DOI： 10.1097/00002030-200302140-00019

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  Prevention of mother-to-child HIV-1 transmission in Burkina Faso: evaluation of vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance.

Authors:  Tani Sagna; Cyrille Bisseye; Tegewende R Compaore; Therese S Kagone; Florencia W Djigma; Djeneba Ouermi; Catherine M Pirkle; Moctar T A Zeba; Valerie J T Bazie; Zoenabo Douamba; Remy Moret; Virginio Pietra; Adjirita Koama; Charlemagne Gnoula; Joseph D Sia; Jean-Baptiste Nikiema; Jacques Simpore
Journal:  Glob Health Action       Date:  2015-01-27       Impact factor: 2.640

2.  Recombinant viruses initiated the early HIV-1 epidemic in Burkina Faso.

Authors:  Peter N Fonjungo; Marcia L Kalish; Amanda Schaefer; Mark Rayfield; Jennifer Mika; Laura E Rose; Orville Heslop; Robert Soudré; Danuta Pieniazek
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

3.  Spatiotemporal dynamics of the HIV-1 subtype G epidemic in West and Central Africa.

Authors:  Edson Delatorre; Daiana Mir; Gonzalo Bello
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

4.  APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.

Authors:  Tegwinde Rebeca Compaore; Serge Theophile Soubeiga; Abdoul Karim Ouattara; Dorcas Obiri-Yeboah; Damehan Tchelougou; Mamoudou Maiga; Maleki Assih; Cyrille Bisseye; Didier Bakouan; Issaka Pierre Compaore; Augustine Dembele; Jeremy Martinson; Jacques Simpore
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.